Better EV Stock: Rivian vs. Lucid

Lucid reported GAAP net losses of $12.09 per share in 2025, along with ongoing capital needs including a combined $1B investment from a Saudi PIF affiliate and Uber plus additional stock issuance, while also dealing with Gravity SUV production issues. Rivian also remains unprofitable (GAAP loss of $3.79 per share and 2025 production down 14%), but revenue/sales strength and two quarters of gross profitability in 2025—supported by its software/services—contrast with Lucid’s repeated dilution and leadership churn. The article argues Rivian is the better bet due to the R2 platform starting around $58,000 and plans for lower-priced $45,000 versions, but stresses investors must be patient given continued EV market difficulty.

Analysis

This is less a “best EV” debate than a capital allocation and survivability screen. RIVN has a cleaner path to defend its equity value because a lower-priced product can widen the buyer pool without requiring a full brand reset; LCID still looks like a recurring financing event disguised as an auto story. In this setup, the market will likely reward evidence of gross margin durability more than delivery growth, because unit gains at premium ASPs can still destroy equity if cash burn stays high.

Second-order, the real loser is not just LCID equity holders but anyone underwriting the story with long-dated capital: each fresh raise raises the hurdle for the next one and keeps dilution embedded in the multiple. For RIVN, the risk is that cheaper trims become margin dilutive before they become volume accretive, especially if demand must be purchased with incentives. That means the stock can work only if R2 cadence is accompanied by improving gross profit per vehicle and not just higher reservations.

The contrarian point: consensus may be underestimating how fragile the “RIVN is the winner” narrative is if the mass-market EV buyer remains rate-sensitive and $45k is still too expensive. Conversely, LCID may be more of a financing optionality trade than a fundamental one; if its backers keep funding it, the equity can stay alive longer than shorts expect. The key falsifiers are delayed R2 commercialization, worsening gross margin, or a cleaner-than-expected LCID funding solution that removes the dilution overhang.

Key Decisions for Investors

• Relative value: long RIVN / short LCID over 3-6 months, sized beta-neutral. Thesis is that RIVN’s product roadmap gives it operating leverage optionality, while LCID remains hostage to dilution. Exit if LCID secures non-dilutive funding or if RIVN R2 timing slips materially.
• If looking for expression with defined risk, buy a 12-18 month RIVN call spread on pullbacks rather than chasing common stock. You want upside exposure to an R2 re-rating without paying full valuation for execution risk.
• Treat LCID as a tactical short only on strength into financing optimism, not a structural short at any price. The risk/reward is poor if the market continues to underwrite Saudi support; use tight risk controls and cover on any credible capital solution.
• Watch the next two reporting cycles for RIVN gross profit per vehicle and R2 production cadence. If gross margin stalls while ASPs fall, the market will likely punish the stock before delivery numbers matter.